About GE’s healthymagination Challenge: Assembling Tools to Fight Cancer is an open call to action for businesses, entrepreneurs, innovators and students with breakthrough ideas for accelerating early detection and enabling more personalized treatment for breast cancer.

The Challenge, launched in collaboration with leading venture capital firms Kleiner Perkins Caufield & Byers, Venrock, Mohr Davidow, and MPM Capital is part of GE’s healthymagination initiative, a global commitment to bringing better health to more people.
How it Works
The healthymagination Challenge is focused on finding new ideas that accelerate innovation in early diagnosis, patient stratification, and the personalized treatment of breast cancer. Specific sub-challenges will be run during different portions of the healthymagination Challenge. From September 15, 2011, until November 20, 2011, the sub-challenges are:
  1. Breast cancer pathways: Map breast cancer pathways independent of classic hormone dependent signaling and how those pathways relate to “triple negative” breast cancer (her 2, estrogen and progesterone receptor negative) – identify possible diagnostics and potential targeted treatments.
  2. Molecular similarities between tumors: Map the molecular/proteomic similarities between breast cancer and other solid tumors especially as it relates to the establishment of a tissue independent classification of cancer and pathway centric therapeutic intervention.


When preparing your submission, please consider:
Originality
We are looking for innovative breast cancer solutions. Is your entry unique?
Feasibility
We are looking for functional solutions that can enjoy success in the global marketplace. Is your entry cost-effective, or can it be made so?
Impact
If successfully realized, will your entry help turn our cancer challenge into a meaningful opportunity?
Submit
Submissions for the first challenge will close on November 20, 2011

All entries must include a clear, detailed proposal describing an innovative, original breast cancer detection, diagnosis, or treatment technology or process.

Fill out the submission form and be sure to have the following prepared:
  • A Short Description for the public (300 word max)
  • Images, Video or other media that help explain the idea
  • A Long Description for the judges that explains your idea in detail (500 word max)
  • Additional materials for the judges that support your proposal (this may include presentations, videos, images. etc.)
  • A valid phone number and mailing address
Share
All entries are the intellectual property of the entrants. GE reserves the right to review entries and post a reasonable amount of information about them on the challenge.healthymagination.com site. After submission, if your proposal meets the contest’s guidelines, you will receive an email link to your idea’s page. Please feel free to share this information with other people.
Review
There are two groups that will evaluate all submissions. One group will specifically target commercial investment and the other will focus on seed money awards for the best early ideas, data solutions and scientific development.

Commercial investment: Representatives of GE and its investment partners Kleiner Perkins Caufield & Beyers, Venrock Capital, Mohr Davidow, and MPM Capital will form an evaluation committee to consider possible investments in you or your company.

Seed awards: GE has also invited an independent panel of judges, including representatives from academia, venture capital firms, government research specialists and others who will award special seed money grants for promising ideas, technologies and data innovations.

The panel of judges will select the entries to receive cash awards. The judging panel will evaluate each entry based on merit; scientific foundation; innovative character; potential to significant impact; economic viability and sustainability and other factors deemed appropriate by the judges.

By the end of January, 2012, GE will have announced those entrants with whom GE intends to pursue commercial relationships and any business deals with GE that have been formalized.
Share
GE will present each of five innovation challenge award recipients with $100,000 in cash, for a total of $500,000, to acknowledge these entries as examples of outstanding entrepreneurship and innovation.

The evaluation committee will consider one or more of the following for selected Challenge entrants:
  • An equity investment by GE or others
  • A cooperative agreement to develop a product or technology
  • A review of your product or service for possible qualification to be a part of the GE healthymagination program
Awards
  1. Up to $100 million in capital funds from GE and its VC partners may be invested globally into promising startups and ideas.
  2. The independent panel of judges will determine awards of $10,000-$100,000 depending on each specific challenge. At least one (1) seed award of $100,000, in cash, will be awarded to an entry in each of the sub-challenges announced today, for Breast Cancer Pathways and Molecular Similarities Between Tumors.
  3. Evaluation of an entrant’s business strategy will be conducted through in-depth discussions with GE’s technical and commercial teams.
  4. Leveraging GE’s technical infrastructure and GE Global Research Centers to accelerate technology and product development
  5. Exploration of partnership opportunities with GE to scale a business and create a global reach.
Participation
Any individual 18 years old or older can participate, as can any organization, except a bankrupt person or organization and/or a person convicted of a crime under any national penal system as defined in the Official Rules. (GE employees and contractors are not eligible to enter.)

If you are participating as a team, one designated team leader must be solely responsible for all activities related to the competition.

For more information, please read the full Terms and Conditions (these are the legal terms that control the healthymagination Challenge), our FAQs or contact us at healthymagination.challenge@ge.com.
Current Challenges
Breast Cancer Pathways:
An open call for innovative ideas, technologies, and processes that will map breast cancer pathways, independent of classic hormone dependent signaling, focusing on how these pathways relate to “triple negative” breast cancer (her 2, estrogen, and progesterone receptor negative). We're looking to crack the code and identify possible diagnostic and targeted treatments.
Molecular Similarities Between Tumors:
An open call for groundbreaking ideas, technologies, and processes that will map the molecular/proteomic similarities between breast cancer and other solid tumors. We’re especially interested in the relation to the establishment of a tissue independent classification system of cancer and new pathway centric therapeutic interventions.